CompletedPhase 2NCT00971789
Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes
Studying PTEN hamartoma tumor syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Arun Rajan, M.D., M.DNational Cancer Institute (NCI)
- Intervention
- fludeoxyglucose F 18(radiation)
- Enrollment
- 18 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2008 – 2012
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00971789 on ClinicalTrials.govOther trials for PTEN hamartoma tumor syndrome
Additional recruiting or active studies for the same condition.